Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis Correspondence


Authors: Alsouqi, A.; Ahmed, G.; Wang, J.; Cassanello, G.; Szabo, A.; Rojek, A. E.; Riedell, P. A.; Awan, F.; Samples, L.; Shadman, M.; Hu, M.; Bachanova, V.; Wesson, W.; Ahmed, N.; Iqbal, M.; Kharfan-Dabaja, M. A.; Scordo, M.; Johnson, P. C.; Chen, Y. B.; Ito, S.; Hamadani, M.; Frigault, M.
Title: Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis
Keywords: adult; controlled study; aged; middle aged; major clinical study; overall survival; clinical trial; neurotoxicity; outcome assessment; letter; progression free survival; hematopoietic stem cell transplantation; central nervous system tumor; central nervous system; central nervous system neoplasms; b cell lymphoma; multicenter study; lymphoma; chimeric antigen receptor; therapy; adoptive immunotherapy; immunotherapy, adoptive; immunocompetent cell; non-hodgkin lymphoma; clinical outcome; diffuse large b cell lymphoma; tocilizumab; humans; human; male; female; secondary central nervous system lymphoma; pulmonary amyloidosis; central nervous system cancer; bruton tyrosine kinase inhibitor; chimeric antigen receptor immunotherapy; receptors, chimeric antigen
Journal Title: American Journal of Hematology
Volume: 99
Issue: 8
ISSN: 0361-8609
Publisher: John Wiley & Sons, Inc.  
Date Published: 2024-08-01
Start Page: 1624
End Page: 1627
Language: English
DOI: 10.1002/ajh.27354
PUBMED: 38769663
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Scordo
    365 Scordo